Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda Falcini

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|November 3, 2012
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian RegistryMaria E Zannin, Carolina Birolo, Valeria M Gerloni, et al.
Arthritis and Rheumatism|February 5, 2005
A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety resultsNicolino Ruperto, Irina Nikishina, Evgueni D Pachanov, et al.
Arthritis and Rheumatism|July 13, 2004
A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexateNicolino Ruperto, Kevin J Murray, Valeria Gerloni, et al.
Arthritis and Rheumatism|November 30, 2006
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international databaseGiorgia Martini, Ivan Foeldvari, Ricardo Russo, et al.
The Journal of Rheumatology|April 17, 2018
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic ArthritisVanessa Cecchin, Maria Elisabetta Zannin, Daniele Ferrari, et al.
Arthritis and Rheumatism|September 6, 2005
The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core setNicolino Ruperto, Angelo Ravelli, Ruben Cuttica, et al.
Annals of the Rheumatic Diseases|May 20, 2017
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national studyRoberta Caorsi, Federica Penco, Alice Grossi, et al.
Italian Journal of Pediatrics|August 31, 2018
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risksAlessandra Marchesi, Isabella Tarissi de Jacobis, Donato Rigante, et al.
Italian Journal of Pediatrics|August 31, 2018
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phaseAlessandra Marchesi, Isabella Tarissi de Jacobis, Donato Rigante, et al.
Arthritis Care & Research|March 2, 2010
Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patientsAngelo Ravelli, Lucia Trail, Cristina Ferrari, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|November 3, 2012
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian RegistryMaria E Zannin, Carolina Birolo, Valeria M Gerloni, et al.
Arthritis and Rheumatism|February 5, 2005
A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety resultsNicolino Ruperto, Irina Nikishina, Evgueni D Pachanov, et al.
Arthritis and Rheumatism|July 13, 2004
A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexateNicolino Ruperto, Kevin J Murray, Valeria Gerloni, et al.
Arthritis and Rheumatism|November 30, 2006
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international databaseGiorgia Martini, Ivan Foeldvari, Ricardo Russo, et al.
The Journal of Rheumatology|April 17, 2018
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic ArthritisVanessa Cecchin, Maria Elisabetta Zannin, Daniele Ferrari, et al.
Arthritis and Rheumatism|September 6, 2005
The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core setNicolino Ruperto, Angelo Ravelli, Ruben Cuttica, et al.
Annals of the Rheumatic Diseases|May 20, 2017
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national studyRoberta Caorsi, Federica Penco, Alice Grossi, et al.
Italian Journal of Pediatrics|August 31, 2018
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risksAlessandra Marchesi, Isabella Tarissi de Jacobis, Donato Rigante, et al.
Italian Journal of Pediatrics|August 31, 2018
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phaseAlessandra Marchesi, Isabella Tarissi de Jacobis, Donato Rigante, et al.
Arthritis Care & Research|March 2, 2010
Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patientsAngelo Ravelli, Lucia Trail, Cristina Ferrari, et al.
Pageof 7